Referral of Morphine Sulfate for the Conduct of Pediatric Studies

Özet

The Food and Drug Administration (FDA) is announcing the referral of morphine sulfate to the Foundation for the National Institutes of Health (the Foundation) for the conduct of pediatric studies. FDA referred the drug to the Foundation on September 29, 2003, and is publishing this notice of the referral in accordance with the Best Pharmaceuticals for Children Act (BPCA).